Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia

Br J Haematol. 2007 Feb;136(4):673-6. doi: 10.1111/j.1365-2141.2006.06486.x.

Abstract

Although haematopoietic cell transplantation (HCT) is curative for sickle cell anaemia (SCA), concerns about its short- and long-term toxicities limit its application. A potential toxicity is an adverse effect on growth. To identify an HCT growth effect, serial height and weight measurements from 53 children and adolescents with SCA after receiving a transplant were compared to historical controls. Hierarchical Linear Models for longitudinal data were used for analysis. In general growth was not impaired by HCT for SCA in young children; however, diminished growth may occur if HCT is carried out near or during the adolescent growth spurt.

Publication types

  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Age Factors
  • Aging / physiology
  • Anemia, Sickle Cell / drug therapy
  • Anemia, Sickle Cell / physiopathology
  • Anemia, Sickle Cell / therapy*
  • Antisickling Agents / therapeutic use
  • Body Height
  • Bone Marrow Transplantation* / adverse effects
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Growth*
  • Humans
  • Hydroxyurea / therapeutic use
  • Male
  • Weight Gain

Substances

  • Antisickling Agents
  • Hydroxyurea